Yigal Nochomovitz
Stock Analyst at Citigroup
(3.29)
# 2,631
Out of 5,182 analysts
350
Total ratings
46.64%
Success rate
2.75%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $33 → $32 | $22.40 | +42.86% | 3 | May 8, 2026 | |
| ZLAB Zai Lab | Maintains: Buy | $47 → $44 | $18.60 | +136.56% | 10 | May 8, 2026 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $71 → $69 | $26.04 | +164.98% | 12 | May 7, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $80 → $82 | $54.83 | +49.55% | 23 | May 6, 2026 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $242 → $246 | $152.25 | +61.58% | 5 | May 6, 2026 | |
| TVTX Travere Therapeutics | Maintains: Buy | $53 → $59 | $42.60 | +38.50% | 2 | May 5, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $17 → $16 | $8.85 | +80.79% | 9 | May 5, 2026 | |
| KRYS Krystal Biotech | Maintains: Buy | $371 → $378 | $305.71 | +23.65% | 12 | May 5, 2026 | |
| ARVN Arvinas | Maintains: Buy | $21 → $24 | $10.11 | +137.39% | 14 | May 4, 2026 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $33 → $45 | $29.48 | +52.65% | 6 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $282 | $221.41 | +27.37% | 3 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $44 → $41 | $41.03 | -0.07% | 20 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $1.54 | +354.55% | 12 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $26 | $10.06 | +158.45% | 5 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $9 → $13 | $19.96 | -34.85% | 3 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $8.35 | +211.38% | 4 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $41 | $19.64 | +108.76% | 3 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $62 | $14.90 | +316.11% | 4 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $7 | $6.85 | +2.19% | 6 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $8.51 | +5.76% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.1 → $2.3 | $2.00 | +15.00% | 13 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $13.66 | +156.22% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $25.36 | +77.44% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $8 | $9.22 | -13.23% | 10 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $23.41 | +79.41% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $57 | $21.49 | +165.24% | 10 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $65 | $28.32 | +129.52% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $14 | $6.78 | +106.49% | 17 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $399 → $405 | $312.12 | +29.76% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $7.27 | +92.57% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $1.94 | +312.37% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $18.08 | +121.24% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $23.89 | -7.91% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.86 | +383.87% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $3.00 | +366.67% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $2.80 | -57.14% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.58 | +26.58% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $1.73 | +362.43% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $1.27 | -21.26% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $8.34 | +319.66% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $26.12 | +409.19% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.87 | +313.44% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $2.39 | +318.41% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.42 | +748.06% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $7.49 | - | 14 | Sep 28, 2021 |
ACADIA Pharmaceuticals
May 8, 2026
Maintains: Buy
Price Target: $33 → $32
Current: $22.40
Upside: +42.86%
Zai Lab
May 8, 2026
Maintains: Buy
Price Target: $47 → $44
Current: $18.60
Upside: +136.56%
Rigel Pharmaceuticals
May 7, 2026
Maintains: Buy
Price Target: $71 → $69
Current: $26.04
Upside: +164.98%
CRISPR Therapeutics AG
May 6, 2026
Maintains: Buy
Price Target: $80 → $82
Current: $54.83
Upside: +49.55%
Neurocrine Biosciences
May 6, 2026
Maintains: Buy
Price Target: $242 → $246
Current: $152.25
Upside: +61.58%
Travere Therapeutics
May 5, 2026
Maintains: Buy
Price Target: $53 → $59
Current: $42.60
Upside: +38.50%
ORIC Pharmaceuticals
May 5, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $8.85
Upside: +80.79%
Krystal Biotech
May 5, 2026
Maintains: Buy
Price Target: $371 → $378
Current: $305.71
Upside: +23.65%
Arvinas
May 4, 2026
Maintains: Buy
Price Target: $21 → $24
Current: $10.11
Upside: +137.39%
ArriVent BioPharma
Apr 24, 2026
Maintains: Buy
Price Target: $33 → $45
Current: $29.48
Upside: +52.65%
Apr 15, 2026
Maintains: Buy
Price Target: $276 → $282
Current: $221.41
Upside: +27.37%
Apr 1, 2026
Downgrades: Neutral
Price Target: $44 → $41
Current: $41.03
Upside: -0.07%
Mar 27, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $1.54
Upside: +354.55%
Mar 26, 2026
Maintains: Buy
Price Target: $52 → $26
Current: $10.06
Upside: +158.45%
Mar 26, 2026
Maintains: Sell
Price Target: $9 → $13
Current: $19.96
Upside: -34.85%
Mar 18, 2026
Maintains: Buy
Price Target: $22 → $26
Current: $8.35
Upside: +211.38%
Mar 17, 2026
Maintains: Buy
Price Target: $43 → $41
Current: $19.64
Upside: +108.76%
Mar 17, 2026
Maintains: Buy
Price Target: $60 → $62
Current: $14.90
Upside: +316.11%
Mar 13, 2026
Maintains: Neutral
Price Target: $4 → $7
Current: $6.85
Upside: +2.19%
Mar 11, 2026
Maintains: Buy
Price Target: $7 → $9
Current: $8.51
Upside: +5.76%
Mar 10, 2026
Maintains: Buy
Price Target: $2.1 → $2.3
Current: $2.00
Upside: +15.00%
Mar 9, 2026
Maintains: Buy
Price Target: $31 → $35
Current: $13.66
Upside: +156.22%
Mar 5, 2026
Maintains: Buy
Price Target: $44 → $45
Current: $25.36
Upside: +77.44%
Mar 4, 2026
Maintains: Neutral
Price Target: $7 → $8
Current: $9.22
Upside: -13.23%
Mar 3, 2026
Initiates: Buy
Price Target: $42
Current: $23.41
Upside: +79.41%
Mar 2, 2026
Maintains: Buy
Price Target: $51 → $57
Current: $21.49
Upside: +165.24%
Feb 19, 2026
Maintains: Buy
Price Target: $64 → $65
Current: $28.32
Upside: +129.52%
Jan 9, 2026
Maintains: Buy
Price Target: $11 → $14
Current: $6.78
Upside: +106.49%
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $312.12
Upside: +29.76%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $7.27
Upside: +92.57%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $1.94
Upside: +312.37%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $18.08
Upside: +121.24%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $23.89
Upside: -7.91%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $1.86
Upside: +383.87%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $3.00
Upside: +366.67%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $2.80
Upside: -57.14%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.58
Upside: +26.58%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $1.73
Upside: +362.43%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $1.27
Upside: -21.26%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $8.34
Upside: +319.66%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $26.12
Upside: +409.19%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.87
Upside: +313.44%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $2.39
Upside: +318.41%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.42
Upside: +748.06%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $7.49
Upside: -